Clinical trial · Interventional
Communication Issues in Patient and Provider Discussions of Immunotherapy
Communication Issues in Patient/Provider Discussions of Immunotherapy
NCT05873608CI-TRIAL-00107364recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This trials studies communication issues in patient and provider discussions about immunotherapy. The goal of this study is to describe where patients have heard about immunotherapy, what the participants understand about it, how physicians and other healthcare workers describe immunotherapy, and how educational videos may support patient knowledge about immunotherapy.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematopoietic and Lymphoid System Neoplasm | Hematopoietic and Lymphatic System Neoplasm | ALIAS | 0.90 |
| Malignant Solid Neoplasm | Malignant Solid Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Educational video | Other | — | UNRESOLVED |
| Interview | Other | — | UNRESOLVED |
| Observation | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Interview
- description
- Patients and providers undergo observation during a conversation about immunotherapy. Then participate in an interview over 20 minutes.
- interventionNames
- Other: Interview
- Other: Observation
- type
- OTHER
- label
- Aim 4 tests an educational video
- description
- The participants watch a video and their comprehension is tested in a pre and post methodology
- interventionNames
- Other: Educational video
Primary outcomes (4)
- measure
- Misestimations about the risks and benefits of immunotherapy resulting from media hype or other sources
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * AIMS 1-3: All patients and providers who may have a discussion about immunotherapy at the Winship Cancer Institute * AIM 4: Any cancer patient
References
Publications (0)
Data not yet available
No reference posted for this study.